POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events

Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Verardi, L.
  • De Lorenzis, E.
  • Pellegrino, G.
  • Di Donato, S.
  • De Luca, G.
  • Campochiaro, C.
  • Cacciapaglia, F.
  • Lepri, G.
  • Cometi, L.
  • Armentano, G.
  • De Pinto, M.
  • Motta, F.
  • Cerasuolo, P.G.
  • De Santis, M.
  • Giuggioli, D.
  • Iannone, F.
  • Del Papa, N.
  • Guiducci, S.
  • Riccieri, V.
  • Bosello, S.L.
  • D'agostino, M.A.
  • Del Galdo, F. ORCID logo https://orcid.org/0000-0002-8528-2283
Keywords: Disease-modifying drugs (DMARDs); Safety; Systemic sclerosis
Dates:
  • Published (online): 30 May 2023
  • Published: June 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Apr 2024 13:26
Last Modified: 23 Apr 2024 13:26
Published Version: https://ard.bmj.com/content/82/Suppl_1/1012.1
Status: Published
Identification Number: https://doi.org/10.1136/annrheumdis-2023-eular.5569

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics